Strategy & Operations News

Corporate plans, restructuring, investments, and operating updates.

RAREUltragenyx Pharmaceutical Inc.

Ultragenyx Targets 2027 Profitability and $1 Billion Revenue

Ultragenyx Pharmaceutical said it expects to become profitable in 2027, with revenue approaching $1 billion that year, executives told investors at the UBS Global Biopharma Conference. Chief Executive Emil Kakkis described the expected profitability as meaningful and tied the outlook to lower spending, growing sales of the company's existing rare-disease therapies and the launch of two gene therapies.

BRK-ABerkshire Hathaway Inc.

Berkshire's Q3 Filing Shows Delta, Lennar Adds and Bank of America Cuts

Berkshire Hathaway's latest quarterly holdings disclosure showed the conglomerate adding to Delta Air Lines and homebuilder Lennar while cutting back on Bank of America, Capital One and VeriSign during the third quarter. The filing listed positions as of Sept. 30 and marked a third consecutive quarter of portfolio changes under Greg Abel, who took over after Warren Buffett retired at the end of last year.

6 stories